| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.27 | 0.09 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |